Financial Consulate’s Tandem Diabetes Care TNDM Stock Holding History

Financial Consulate’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$66	Buy	+4	New	+$75	﹤0.01%	1847

Other funds holding TNDM

Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

Financial Consulate's TNDM Position: Q3 2026 in Review

Financial Consulate opened a new position in Tandem Diabetes Care (TNDM) in Q3 2026: 4 shares worth $66. The stake represents ﹤0.01% of the portfolio and ranks #1847 among its holdings.

37 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

Financial Consulate held 4 shares of Tandem Diabetes Care worth $66 as of Q3 2026.
Tandem Diabetes Care was a new Financial Consulate position in Q3 2026.
Tandem Diabetes Care made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1847 holding.
37 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.